NCT07474324
- Conditions
- GC/GEJC
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
Clinical trial condition
GC/GEJC
Explore clinical trials studying GC/GEJC. Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
GC/GEJC trial results
NCT06506292
- Conditions
- Adebrelimab (SHR-1316), GC/GEJC, XELOX
- Locations
-
- Tianjin Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
NCT07701681
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +17 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT07680569
- Conditions
- GC/GEJC
- Locations
-
Not specified
Not Yet Recruiting
Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC
NCT06684158
- Conditions
- GC/GEJC
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China